Use of vascular cells to create the conventional outflow tract

Patent metadata

Field	Value
Publication number	US-2019017017-A1
Application number	US-201816044806-A
Country	US
Kind code	A1
Filing date	Jul 25, 2018
Priority date	Jan 25, 2016
Publication date	Jan 17, 2019
Grant date	—

Abstract

Provided is a system for modeling the conventional outflow tract, including: a porous scaffold with trabecular meshwork cells attached to one surface and microvascular endothelial cells co-cultured on an opposite surface transforming the microvascular endothelial cells into Schlemm's canal cell-like cells. Also provided is a method for using the system for screening by contacting the cells with a known or suspected medicament and measuring its effects on the system such as flow of a perfusate. Also provided is a method of making the system by fabricating the porous substrate as a micropatterned scaffold.

First claim

What is claimed is:

1 . A system for modeling a conventional outflow tract, comprising:
a porous scaffold comprising a first surface and a second surface and the first surface is on a side opposite the second surface; a plurality of trabecular meshwork cells attached to the first surface and extending into a plurality of pores in the porous scaffold; and a plurality of second cells attached to the second surface and extending into the plurality of pores, wherein the second cells comprise microvascular endothelial cells that were co-cultured on the scaffold with the plurality of trabecular meshwork cells for a period of time to form Schlemm's canal cell-like cells, Schlemm's canal cells, or both.

2 . The system of claim 1 , wherein the porous scaffold comprises a micropatterned substrate.

3 . The system of claim 2 , wherein the micropatterned substrate comprises a photoresist, a thermoplastic polymer, or a thermoset polymer.

4 . The system of claim 1 , wherein the porous scaffold comprises a coating.

5 . The system of claim 1 , wherein the porous scaffold comprises a pore width of between 200 nm and 1 μm, between 1 μm and 5 μm, between 5 μm and 10 μm, between 10 μm and 15 μm, between 15 μm and 20 μm, or between 7 μm and 15 μm.

6 . The system of claim 1 , wherein the plurality of trabecular meshwork cells, the plurality of second cells, or both, are transfected or are contacted with a known or suspected medicament or a compound known or suspected to impair, enhance, ameliorate, or improve conventional outflow tract function.

7 . A method for screening employing the system of claim 1 , comprising:
a) obtaining the porous scaffold having the plurality of trabecular meshwork cells and the plurality of second cells attached thereto, the plurality of trabecular meshwork cells having been formed by seeding and growing the plurality of trabecular meshwork cells on the first surface, the plurality of second cells having been formed by seeding and growing the plurality of second cells on the second surface, wherein the second cells comprise microvascular endothelial cells that were co-cultured with the plurality of trabecular meshwork cells on the first surface for a period of time at least until the plurality of microvascular endothelial cells were transformed into a plurality of Schlemm's canal cell-like cells, a plurality of Schlemm's canal cells, or both; b) contacting the plurality of trabecular meshwork cells, the plurality of second cells, or both, with a known or suspected medicament or a compound known or suspected to impair, enhance, ameliorate, or improve conventional outflow tract function, or transfecting the plurality of trabecular meshwork cells, the plurality of second cells, or both; c) perfusing fluid through the plurality of trabecular meshwork cells and the plurality of second cells; and d) measuring a transmembrane pressure, a flow rate, a through-flow, a resistance to flow, a hydraulic conductivity, an electrical conductivity, a vacuole dynamics, a pore formation, a biomarker analysis of a perfusate, or an outflow facility of the plurality of trabecular meshwork cells and the second cells.

8 . The method of claim 7 , wherein the seeding and growing of the plurality of trabecular meshwork cells comprises seeding at an initial density of trabecular meshwork cells of greater than 10,000 cells/cm 2 .

9 . The method of claim 7 , wherein the seeding and growing of the plurality of second cells comprises seeding at an initial density of second cells of greater than 10,000 cells/cm 2 .

10 . A method of making the system for modeling a conventional outflow tract of claim 1 , comprising:
obtaining a porous scaffold wherein the porous scaffold comprises a first surface and a second surface and the first surface is on a side opposite the second surface; seeding and growing a plurality of trabecular meshwork cells on the first surface; and seeding and growing a plurality of second cells on the second surface wherein the second cells comprise Schlemm's canal cells or are microvascular endothelial cells and co-culturing the plurality of trabecular meshwork cells on the first surface for a period of time at least until the plurality of microvascular endothelial cells are transformed into a plurality of Schlemm's canal cell-like cells.

11 . A system for modeling a conventional outflow tract, comprising:
a porous scaffold comprising a first surface and a second surface and the first surface is on a side opposite the second surface; a plurality of first cells attached to the first surface and extending into a plurality of pores in the porous scaffold, wherein the first cells comprise trabecular meshwork cells, stem cells that can differentiate into trabecular meshwork cells, precursor trabecular meshwork cells, or any combination of two or more of the foregoing; and a plurality of second cells attached to the second surface and extending into the plurality of pores, wherein the second cells comprise microvascular endothelial cells that were co-cultured on the scaffold with the plurality of first cells for a period of time to form Schlemm's canal cell-like cells, stem cells that can differentiate into vascular endothelial cells that were co-cultured on the scaffold with the plurality of first cells for a period of time to form Schlemm's canal cell-like cells, precursor vascular endothelial cells that were co-cultured on the scaffold with the plurality of first cells for a period of time to form Schlemm's canal cell-like cells, stem cells that can differentiate into Schlemm's canal cells that were co-cultured on the scaffold with the plurality of first cells for a period of time to form Schlemm's canal cell-like cells, Schlemm's canal cells, or any combination of two or more of the foregoing.

12 . The system of claim 11 , wherein the porous scaffold comprises a micropatterned substrate.

13 . The system of claim 12 , wherein the micropatterned substrate comprises a photoresist, a thermoplastic polymer, or a thermoset polymer.

14 . The system of claim 11 , wherein the porous scaffold comprises a coating.

15 . The system of claim 11 , wherein the porous scaffold comprises a pore width of between 200 nm and 1 μm, between 1 μm and 5 μm, between 5 μm and 10 μm, between 10 μm and 15 μm, between 15 μm and 20 μm, or between 7 μm and 15 μm.

16 . The system of claim 11 , wherein the plurality of trabecular meshwork cells, the plurality of second cells, or both, are transfected or are contacted with a known or suspected medicament or a compound known or suspected to impair, enhance, ameliorate, or improve conventional outflow tract function.

17 . A method for screening employing the system of claim 11 , comprising:
a) obtaining the porous scaffold having the plurality of first cells and the plurality of second cells attached thereto; b) contacting the plurality of first cells, the plurality of second cells, or both, with a known or suspected medicament or a compound known or suspected to impair, enhance, ameliorate, or improve conventional outflow tract function, or transfecting the plurality of first cells, the plurality of second cells, or both; c) perfusing fluid through the plurality of first cells and the plurality of second cells; and d) measuring a transmembrane pressure, a flow rate, a through-flow, a resistance to flow, a hydraulic conductivity, an electrical conductivity, a vacuole dynamics, a pore formation, a biomarker analysis of a perfusate, or an outflow facility of the plurality of first cells and the plurality of second cells.

Assignees

• Univ New York State Res Found

Inventors

• Xie Yubing
• Torrejon Karen
• Sharfstein Susan
• Bergkvist Magnus
• Danias John
• Dautriche Cula N

Classifications

• C12M25/14

  Scaffolds; Matrices (in general C12N5/0068) · CPC title

• C12N5/0621 Primary

  Eye cells, e.g. cornea, iris pigmented cells (photoreceptors C12N5/062) · CPC title

• C12N2533/52

  Fibronectin; Laminin · CPC title

• C12N2503/02

  Drug screening · CPC title

• C12M35/08

  Chemical, biochemical or biological means, e.g. plasma jet, co-culture · CPC title